Fatma Yılmaz

813 total citations
47 papers, 557 citations indexed

About

Fatma Yılmaz is a scholar working on Oncology, Hematology and Pathology and Forensic Medicine. According to data from OpenAlex, Fatma Yılmaz has authored 47 papers receiving a total of 557 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Hematology and 7 papers in Pathology and Forensic Medicine. Recurrent topics in Fatma Yılmaz's work include COVID-19 Clinical Research Studies (5 papers), Lymphoma Diagnosis and Treatment (5 papers) and Inflammatory Biomarkers in Disease Prognosis (4 papers). Fatma Yılmaz is often cited by papers focused on COVID-19 Clinical Research Studies (5 papers), Lymphoma Diagnosis and Treatment (5 papers) and Inflammatory Biomarkers in Disease Prognosis (4 papers). Fatma Yılmaz collaborates with scholars based in Türkiye, United Kingdom and United States. Fatma Yılmaz's co-authors include Mustafa Cemek, Mehmet Emin Büyükokuroğlu, Turan Karaca, Gülşen Yılmaz, Aliye Baştuğ, Sümeyye Kazancıoğlu, Hürrem Bodur, Bahadır Orkun Özbay, Serpil Erdoğan and Doğan Yücel and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Pharmaceutics and Food and Chemical Toxicology.

In The Last Decade

Fatma Yılmaz

40 papers receiving 537 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fatma Yılmaz Türkiye 11 127 92 74 71 66 47 557
Chien‐Lin Lu Taiwan 20 79 0.6× 72 0.8× 273 3.7× 40 0.6× 75 1.1× 54 1.0k
Peyman Nowrouzi‐Sohrabi Iran 10 187 1.5× 58 0.6× 65 0.9× 99 1.4× 94 1.4× 29 557
Brian Mullan United Kingdom 12 53 0.4× 24 0.3× 112 1.5× 41 0.6× 184 2.8× 22 859
Shahla Rezaei Iran 10 173 1.4× 49 0.5× 83 1.1× 95 1.3× 158 2.4× 31 601
Kashif M. Munir United States 16 40 0.3× 40 0.4× 152 2.1× 32 0.5× 78 1.2× 81 850
Torki Al-Otaibi Kuwait 12 46 0.4× 101 1.1× 140 1.9× 17 0.2× 136 2.1× 72 814
Francesca Coppi Italy 13 40 0.3× 42 0.5× 90 1.2× 49 0.7× 72 1.1× 46 1.1k
Lin Cai China 12 129 1.0× 41 0.4× 75 1.0× 41 0.6× 91 1.4× 44 640
Tae Hyun Ban South Korea 11 54 0.4× 34 0.4× 191 2.6× 30 0.4× 61 0.9× 51 722
Jiaoyue Zhang China 15 433 3.4× 61 0.7× 203 2.7× 225 3.2× 167 2.5× 43 1.1k

Countries citing papers authored by Fatma Yılmaz

Since Specialization
Citations

This map shows the geographic impact of Fatma Yılmaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fatma Yılmaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fatma Yılmaz more than expected).

Fields of papers citing papers by Fatma Yılmaz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fatma Yılmaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fatma Yılmaz. The network helps show where Fatma Yılmaz may publish in the future.

Co-authorship network of co-authors of Fatma Yılmaz

This figure shows the co-authorship network connecting the top 25 collaborators of Fatma Yılmaz. A scholar is included among the top collaborators of Fatma Yılmaz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fatma Yılmaz. Fatma Yılmaz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yılmaz, Fatma, et al.. (2024). Nursing Intervention on Prevention of Lymphedema After Breast Cancer Surgery. DergiPark (Istanbul University). 1 indexed citations
2.
Yılmaz, Fatma, et al.. (2023). Does Systemic Immune Inflammation Index Predicts Survival In Diffuse Large B Cell Lymphoma Patients?. SHILAP Revista de lepidopterología. 5(3). 170–174.
4.
Albayrak, Murat, et al.. (2021). CASE REPORT: FOLLICULAR LYMPHOMA PRESENTED WITH CHYLOTHORAX. Hematology Transfusion and Cell Therapy. 43. S43–S43. 1 indexed citations
5.
Yılmaz, Fatma, et al.. (2021). Antibody False Positivity Among COVID-19 Convalescent Plasma Donors: A Comparative Study from the Turkish Red Crescent Blood Center. SHILAP Revista de lepidopterología. 59(5). 353–357. 4 indexed citations
6.
Yılmaz, Mustafa, et al.. (2021). Association Between COVID-19 and ABO Blood Groups: An Analysis on Convalescent Plasma Donors in Turkey. SHILAP Revista de lepidopterología. 59(1). 7–14. 2 indexed citations
7.
Albayrak, Murat, et al.. (2021). Mean platelet volume is a predictive and prognostic marker for patients with acute myeloid leukemia: a two-center retrospective analysis. Leukemia & lymphoma. 62(11). 2755–2761. 2 indexed citations
8.
Albayrak, Murat, et al.. (2021). Hypercalcemia associated with the interaction between all trans retinoic acid and posaconazole in an acute promyelocytic leukemia case. Journal of Oncology Pharmacy Practice. 27(8). 2027–2029. 6 indexed citations
9.
Yılmaz, Fatma, et al.. (2021). Vitreous hemorrhage: A rare ophthalmic adverse effect due to imatinib treatment. Journal of Oncology Pharmacy Practice. 28(3). 725–728. 2 indexed citations
10.
Kazancıoğlu, Sümeyye, Fatma Yılmaz, Aliye Baştuğ, et al.. (2020). Lymphocyte Subset Alteration and Monocyte CD4 Expression Reduction in Patients with Severe COVID-19. Viral Immunology. 34(5). 342–351. 29 indexed citations
11.
Ulukanlıgil, Mustafa, et al.. (2019). Analysis of the blood donor behaviours: 9 years’ experience of Turkish Red Crescent in blood donor management practice. ISBT Science Series. 14(2). 149–156. 1 indexed citations
12.
Ulukanlıgil, Mustafa, et al.. (2019). The contribution of sociodemographic, attitudinal and satisfactory factors to blood donation frequencies among turkish blood donors. ISBT Science Series. 15(2). 231–242. 2 indexed citations
13.
Akbal, Erdem, Erdem Koçak, Seyfettin Köklü, et al.. (2017). Serum Toll-Like Receptor-2, Toll-Like Receptor-4 Levels in Patients with HBeAg-Negative Chronic Viral Hepatitis B. Viral Immunology. 30(4). 278–282. 5 indexed citations
14.
Yılmaz, Fatma, et al.. (2017). Thiol/disulphide homeostasis in men with heroin addiction. Dusunen Adam The Journal of Psychiatry and Neurological Sciences. 95–100. 5 indexed citations
15.
Ateş, Hale, İhsan Ateş, Harun Kundi, & Fatma Yılmaz. (2016). Choice of marker for assessment of RV dysfunction in acute pulmonary embolism. Herz. 42(8). 758–765. 3 indexed citations
16.
Çakır, B., et al.. (2015). EVALUATION OF THE OXIDATIVE STRESS IN SILICOSIS PATIENTS. DergiPark (Istanbul University). 1 indexed citations
17.
Yılmaz, Fatma, et al.. (2014). Normoglisemik Bireylerde Demir Eksikliği Anemisinin Hemoglobin A1c Düzeylerine Etkisi. Ankara Medical Journal. 14(1).
19.
Çınar, Fatma İlknur, Sedat Yılmaz, Muhammet Çınar, et al.. (2011). Living with scleroderma: patients’ perspectives, a phenomenological study. Rheumatology International. 32(11). 3573–3579. 28 indexed citations
20.
Yağmurdur, Hatice, et al.. (2008). Dexmedetomidine Reduces the Ischemia-Reperfusion Injury Markers During Upper Extremity Surgery With Tourniquet. The Journal Of Hand Surgery. 33(6). 941–947. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026